Actively Recruiting
A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants
Led by AbbVie · Updated on 2026-04-17
32
Participants Needed
1
Research Sites
22 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase 1 study to investigate safety and pharmacokinetics of ABBV-722 and Upadacitinib following multiple oral doses in healthy adult participants.
CONDITIONS
Official Title
A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Laboratory values meet the criteria specified in the protocol.
- General good health based on medical history, physical exam, vital signs, laboratory profile, and 12-lead electrocardiogram (ECG).
You will not qualify if you...
- History of any significant illness, infection, major febrile illness, hospitalization, or surgery within 30 days prior to first dose.
- Chronic recurring infection or active viral infection.
- Consumption of alcohol, grapefruit products, Seville oranges, starfruit products, or quinine/tonic water within 72 hours before study drug administration.
- Use of tobacco or nicotine-containing products within 90 days prior to first dose.
- Evidence of dysplasia or history of malignancy except for certain treated skin or cervical cancers.
- History or evidence of active or latent tuberculosis.
- Prior exposure to ABBV-722 within 90 days prior to first dose.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Acpru /Id# 279285
Grayslake, Illinois, United States, 60030
Actively Recruiting
Research Team
A
ABBVIE CALL CENTER
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here